2 assets in Cancer-Associated Retinopathy

Therapeutic assets addressing Cancer-Associated Retinopathy, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Anti-Cd19 Car T-Cells Cancer-Associated Retinopathy	KK Women's and Children's Hospital	P2	CCC (53)
Thiscart19A Cancer-Associated Retinopathy	The First Affiliated Hospital of Soochow University	P1	CC (43)